Published in J Clin Invest on December 01, 1989
Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med (1992) 2.76
Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29
Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest (2006) 1.69
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2011) 1.58
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27
Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation (2009) 1.13
Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09
Two C-type lectins cooperate to defend Anopheles gambiae against Gram-negative bacteria. J Biol Chem (2009) 1.07
Dictyostelium discoideum mutants with conditional defects in phagocytosis. J Cell Biol (1994) 1.04
Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans. Clin Diagn Lab Immunol (2001) 1.04
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) (2009) 1.03
Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor. J Exp Med (1995) 1.00
Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infect Immun (1993) 0.97
Interactions of human mannose-binding protein with lipoteichoic acids. Infect Immun (1996) 0.95
Immunolocalization of a novel collectin CL-K1 in murine tissues. J Histochem Cytochem (2007) 0.89
The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein. Infect Immun (1996) 0.86
Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun (1998) 0.86
Structure of a truncated human surfactant protein D is less effective in agglutinating bacteria than the native structure and fails to inhibit haemagglutination by influenza A virus. Biochem J (1997) 0.86
The Gly-54-->Asp allelic form of human mannose-binding protein (MBP) fails to bind MBP-associated serine protease. Biochem J (1995) 0.84
Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice. Mol Cell Biol (2002) 0.82
Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation. Infect Immun (1995) 0.82
Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement. Mol Immunol (2010) 0.75
Sub-minimal inhibitory concentrations of cefmetazole enhance serum bactericidal activity in vitro by amplifying poly-C9 deposition. J Clin Invest (1992) 0.75
Detection of T and B cells specific complement-fixing alloantibodies using flow cytometry: A diagnostic approach for a resource limited laboratory. Asian J Transfus Sci (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev (1977) 13.47
Maltose transport in Escherichia coli K-12: involvement of the bacteriophage lambda receptor. J Bacteriol (1975) 5.68
Large scale isolation of functionally active components of the human complement system. J Biol Chem (1981) 5.26
Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci U S A (1977) 4.48
ROUGH MUTANTS OF SALMONELLA TYPHIMURIUM. I. GENETICS. Nature (1964) 3.98
The human mannose-binding protein functions as an opsonin. J Exp Med (1989) 3.15
Complement evasion by bacteria and parasites. Annu Rev Microbiol (1988) 3.11
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med (1989) 2.95
Serum lectin with known structure activates complement through the classical pathway. J Biol Chem (1987) 2.79
Purification and radiolabeling of human C1q. J Immunol (1981) 2.75
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol (1968) 2.68
The alternative pathway C3/C5 convertase: chemical basis of factor B activation. J Immunol (1979) 2.58
A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med (1988) 2.24
Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein. J Biol Chem (1986) 2.10
Isolation and characterization of a mannan-binding protein from rabbit liver. Biochem Biophys Res Commun (1978) 2.04
Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem J (1981) 1.86
The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction. Proc Soc Exp Biol Med (1970) 1.78
A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway. Proc Natl Acad Sci U S A (1973) 1.74
Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component. J Immunol (1974) 1.74
Physicochemical and functional characterization of the C1r subunit of the first complement component. J Immunol (1976) 1.67
Proteins involved in the activation and control of the two pathways of human complement. Biochem Soc Trans (1983) 1.64
Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide. J Bacteriol (1986) 1.61
Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol (1982) 1.45
Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim Biophys Acta (1986) 1.34
Complement activation by polysaccharide of lipopolysaccharide: an important virulence determinant of salmonellae. Infect Immun (1983) 1.34
Effect of the quality of the lipopolysaccharide on mouse virulence of Salmonella enteritidis. Infect Immun (1975) 1.32
The structure and function of vertebrate mannose lectin-like proteins. J Cell Sci Suppl (1988) 1.28
Isolation and characterization of a mannan-binding protein from rat liver. J Biol Chem (1981) 1.28
Antibody-independent interactions between Escherichia coli J5 and human complement components. J Immunol (1981) 1.23
Isolation of mannose-binding proteins from human and rat liver. Biochem J (1983) 1.20
The smooth lipopolysaccharide character of 1,4,(5),12 and 1,9,12 transductants formed as hybrids between groups B and D of salmonella. Eur J Biochem (1971) 1.19
Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol (1981) 1.15
Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B. Proc Natl Acad Sci U S A (1986) 1.14
A group of bactericidal factors conserved by vertebrates for more than 300 million years. J Immunol (1984) 1.06
A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum. J Immunol Methods (1982) 1.02
Mechanism of killing of Giardia lamblia trophozoites by complement. J Clin Invest (1987) 0.98
Antibody-independent C1 activation by E. coli. J Immunol (1984) 0.98
Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. J Immunol (1981) 0.93
Physicochemical properties of a new bactericidal factor, Ra-reactive factor. Biochem Biophys Res Commun (1982) 0.88
Partial amino acid sequence of human factor D:homology with serine proteases. Proc Natl Acad Sci U S A (1980) 0.86
C3b generation is affected by the structure of the O-antigen polysaccharide in lipopolysaccharide from salmonellae. J Immunol (1987) 0.86
Interaction of Neisseria gonorrhoeae with classical complement components, C1-inhibitor, and a monoclonal antibody directed against the Neisserial H.8 antigen. J Clin Invest (1989) 0.78
Phylogenetic perspectives in innate immunity. Science (1999) 9.42
Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med (1985) 3.44
The human mannose-binding protein functions as an opsonin. J Exp Med (1989) 3.15
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97
A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med (1989) 2.95
Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia. J Exp Med (1981) 2.89
Purification and radiolabeling of human C1q. J Immunol (1981) 2.75
The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc Natl Acad Sci U S A (1994) 2.70
Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53
Pathogenesis of Campylobacter fetus infections. Failure of encapsulated Campylobacter fetus to bind C3b explains serum and phagocytosis resistance. J Clin Invest (1988) 2.38
The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol (1998) 2.31
Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity (1996) 2.30
Requirement for croquemort in phagocytosis of apoptotic cells in Drosophila. Science (1999) 2.29
The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J Cell Biol (1994) 2.26
The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci U S A (1994) 2.22
Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interaction. J Cell Sci (1997) 2.16
Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics (1999) 2.12
Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP. J Immunol (1986) 2.09
Safe haven: the cell biology of nonfusogenic pathogen vacuoles. Annu Rev Microbiol (1997) 2.07
Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol (2000) 1.96
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr (1998) 1.95
Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo. J Bacteriol (1987) 1.93
Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol (1984) 1.87
Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement. J Clin Invest (1985) 1.86
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol (1986) 1.82
Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest (1993) 1.80
Kinetics and pattern of organelle exocytosis during Toxoplasma gondii/host-cell interaction. Parasitol Res (1993) 1.76
The parasitophorous vacuole membrane surrounding Plasmodium and Toxoplasma: an unusual compartment in infected cells. J Cell Sci (1998) 1.73
CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol (1989) 1.72
The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasitophorous vacuole membrane. J Cell Biol (2001) 1.69
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol (2001) 1.66
Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet (1992) 1.66
Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science (1999) 1.65
The human mannose-binding protein gene. Exon structure reveals its evolutionary relationship to a human pulmonary surfactant gene and localization to chromosome 10. J Exp Med (1989) 1.64
Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med (1983) 1.63
Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest (1998) 1.61
Down-regulation of mannosyl receptor-mediated endocytosis and antigen F4/80 in bacillus Calmette-Guérin-activated mouse macrophages. Role of T lymphocytes and lymphokines. J Exp Med (1982) 1.61
Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol Med (1994) 1.60
The serum mannose-binding protein and the macrophage mannose receptor are pattern recognition molecules that link innate and adaptive immunity. Semin Immunol (1998) 1.60
cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity (1997) 1.58
Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms. Nat Cell Biol (2000) 1.57
Drosophila scavenger receptor CI is a pattern recognition receptor for bacteria. Immunity (2001) 1.52
Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun (1983) 1.51
Modulation of FcR function by complement: subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J Immunol (1987) 1.51
Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan. J Exp Med (1988) 1.51
Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol (1993) 1.50
Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma. Proc Natl Acad Sci U S A (1988) 1.47
The collectins in innate immunity. Curr Opin Immunol (1996) 1.46
Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. J Clin Invest (1995) 1.45
Analysis of receptor-mediated C1q binding to human peripheral blood mononuclear cells. J Immunol (1980) 1.43
Treatment of l(2)mbn Drosophila tumorous blood cells with the steroid hormone ecdysone amplifies the inducibility of antimicrobial peptide gene expression. Insect Biochem Mol Biol (1997) 1.43
Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol (1994) 1.42
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Infect Immun (1984) 1.42
What is the best way to treat inherited disorders? N Engl J Med (2001) 1.40
Human mannose-binding protein carbohydrate recognition domain trimerizes through a triple alpha-helical coiled-coil. Nat Struct Biol (1994) 1.39
Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor. J Exp Med (1992) 1.38
beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol (1994) 1.38
Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. J Exp Med (1992) 1.36
Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging (1997) 1.36
Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest (1985) 1.35
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
Localization and cell association of C1q in Alzheimer's disease brain. Exp Neurol (1996) 1.32
Tandemly repeated genes encode nucleoside triphosphate hydrolase isoforms secreted into the parasitophorous vacuole of Toxoplasma gondii. J Biol Chem (1994) 1.32
Classical complement pathway activation by antipneumococcal antibodies leads to covalent binding of C3b to antibody molecules. Infect Immun (1983) 1.31
Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect Immun (1997) 1.31
Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody. Curr Top Microbiol Immunol (1985) 1.29
The protozoan parasite Toxoplasma gondii targets proteins to dense granules and the vacuolar space using both conserved and unusual mechanisms. J Cell Biol (1998) 1.27
A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4. J Immunol (1984) 1.26
Toll-like receptors as sensors of pathogens. Pediatr Res (2001) 1.26
A quantitative model for subcutaneous abscess formation in mice. Br J Exp Pathol (1980) 1.26
Identification of types of cells in human peripheral blood that bind C1q. J Immunol (1981) 1.25
Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother (1989) 1.25
Laminin enhances binding of Toxoplasma gondii tachyzoites to J774 murine macrophage cells. Infect Immun (1992) 1.25
Bactericidal but not nonbactericidal C5b-9 is associated with distinctive outer membrane proteins in Neisseria gonorrhoeae. J Immunol (1985) 1.25
Macrophage activation in murine African trypanosomiasis. Infect Immun (1983) 1.24
Heparin-binding EGF-like growth factor: characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues. Biochem Biophys Res Commun (1993) 1.22
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. J Immunol (1985) 1.22
Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med (1994) 1.22
Targeted reduction of nucleoside triphosphate hydrolase by antisense RNA inhibits Toxoplasma gondii proliferation. J Biol Chem (1999) 1.22
Upstream elements required for expression of nucleoside triphosphate hydrolase genes of Toxoplasma gondii. Mol Biochem Parasitol (1998) 1.21
Interferon alpha/beta selectively antagonises down-regulation of mannosyl-fucosyl receptors on activated macrophages by interferon gamma. Biochem Biophys Res Commun (1986) 1.21
Influence of lipoteichoic acid structure on recognition by the macrophage scavenger receptor. Infect Immun (1996) 1.20
Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa. Infect Immun (1986) 1.20
Complement component C1q modulates the phagocytosis of Abeta by microglia. Exp Neurol (2000) 1.19
Laminin on Toxoplasma gondii mediates parasite binding to the beta 1 integrin receptor alpha 6 beta 1 on human foreskin fibroblasts and Chinese hamster ovary cells. Infect Immun (1992) 1.18
Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J Immunol (1982) 1.17
Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol (1990) 1.17
Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity. J Neurochem (2004) 1.16
Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology. Antimicrob Agents Chemother (1997) 1.16
Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis. J Biol Chem (1991) 1.16
Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol (1997) 1.16
Molecular characterization of the mouse mannose-binding proteins. The mannose-binding protein A but not C is an acute phase reactant. J Immunol (1991) 1.15
Directing an appropriate immune response: the role of defense collagens and other soluble pattern recognition molecules. Curr Drug Targets (2008) 1.15
Antibiotic levels in infected and sterile subcutaneous abscesses in mice. J Infect Dis (1981) 1.14